@article{decroisette:hal-03924732,
TITLE = {A phase II trial of nivolumab and denosumab association as second-line treatment for stage IV non-small-cell lung cancer (NSCLC) with bone metastases: DENIVOS study (GFPC 06-2017)},
AUTHOR = {Decroisette, C and Monnet, I. and Ricordel, C and Demaegdt, A. and Falchero, L and Bylicki, O. and Geier, M. and Justeaux, G. and Bernardi, M. and Andre, M. and Guisier, F. and Fournel, P and Vieillot, S. and Hauss, P.-A. and Schott, R and Crequit, J. and Auliac, J. B. and Chouaid, C and Greillier, L},
URL = {https://hal.science/hal-03924732},
JOURNAL = {Annals of Oncology},
PUBLISHER = {Elsevier},
VOLUME = {33},
NUMBER = {7},
PAGES = {S1028-S1029},
YEAR = {2022},
MONTH = Sep, DOI = {10.1016/j.annonc.2022.07.1161},
HAL_ID = {hal-03924732},
HAL_VERSION = {v1},
}